ID AAKG2_MOUSE Reviewed; 566 AA. AC Q91WG5; E9QK80; Q6V7V5; DT 13-SEP-2005, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 2. DT 09-DEC-2015, entry version 112. DE RecName: Full=5'-AMP-activated protein kinase subunit gamma-2; DE Short=AMPK gamma2; DE Short=AMPK subunit gamma-2; GN Name=Prkag2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B). RC STRAIN=C57BL/6J; RA Zhou G., Jiang D., Zhang Y.; RT "Cloning of mouse protein kinase, AMP-activated, gamma 2 non-catalytic RT subunit."; RL Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., RA She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., RA Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., RA Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J., RA Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., RA Lindblad-Toh K., Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of RT the mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A). RC STRAIN=FVB/N; TISSUE=Kidney; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-71; SER-73; RP SER-90; SER-138; SER-143; SER-158; SER-161 AND SER-196, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=17242355; DOI=10.1073/pnas.0609836104; RA Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; RT "Large-scale phosphorylation analysis of mouse liver."; RL Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). RN [5] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-71; SER-143; RP SER-161; SER-162 AND THR-165, AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Pancreas, RC and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and RT expression."; RL Cell 143:1174-1189(2010). RN [6] RP PHOSPHORYLATION BY ULK1. RX PubMed=21460634; DOI=10.4161/auto.7.7.15451; RA Loffler A.S., Alers S., Dieterle A.M., Keppeler H., Franz-Wachtel M., RA Kundu M., Campbell D.G., Wesselborg S., Alessi D.R., Stork B.; RT "Ulk1-mediated phosphorylation of AMPK constitutes a negative RT regulatory feedback loop."; RL Autophagy 7:696-706(2011). CC -!- FUNCTION: AMP/ATP-binding subunit of AMP-activated protein kinase CC (AMPK), an energy sensor protein kinase that plays a key role in CC regulating cellular energy metabolism. In response to reduction of CC intracellular ATP levels, AMPK activates energy-producing pathways CC and inhibits energy-consuming processes: inhibits protein, CC carbohydrate and lipid biosynthesis, as well as cell growth and CC proliferation. AMPK acts via direct phosphorylation of metabolic CC enzymes, and by longer-term effects via phosphorylation of CC transcription regulators. Also acts as a regulator of cellular CC polarity by remodeling the actin cytoskeleton; probably by CC indirectly activating myosin. Gamma non-catalytic subunit mediates CC binding to AMP, ADP and ATP, leading to activate or inhibit AMPK: CC AMP-binding results in allosteric activation of alpha catalytic CC subunit (PRKAA1 or PRKAA2) both by inducing phosphorylation and CC preventing dephosphorylation of catalytic subunits. ADP also CC stimulates phosphorylation, without stimulating already CC phosphorylated catalytic subunit. ATP promotes dephosphorylation CC of catalytic subunit, rendering the AMPK enzyme inactive (By CC similarity). {ECO:0000250}. CC -!- SUBUNIT: AMPK is a heterotrimer of an alpha catalytic subunit CC (PRKAA1 or PRKAA2), a beta (PRKAB1 or PRKAB2) and a gamma non- CC catalytic subunits (PRKAG1, PRKAG2 or PRKAG3). Interacts with CC FNIP1 and FNIP2 (By similarity). {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=A; CC IsoId=Q91WG5-1; Sequence=Displayed; CC Name=B; CC IsoId=Q91WG5-2; Sequence=VSP_015586; CC -!- DOMAIN: The AMPK pseudosubstrate motif resembles the sequence CC around sites phosphorylated on target proteins of AMPK, except the CC presence of a non-phosphorylatable residue in place of Ser. In the CC absence of AMP this pseudosubstrate sequence may bind to the CC active site groove on the alpha subunit (PRKAA1 or PRKAA2), CC preventing phosphorylation by the upstream activating kinase CC STK11/LKB1 (By similarity). {ECO:0000250}. CC -!- DOMAIN: The CBS domains mediate binding to AMP, ADP and ATP. 2 CC sites bind either AMP or ATP, whereas a third site contains a CC tightly bound AMP that does not exchange. Under physiological CC conditions AMPK mainly exists in its inactive form in complex with CC ATP, which is much more abundant than AMP (By similarity). CC {ECO:0000250}. CC -!- PTM: Phosphorylated by ULK1; leading to negatively regulate AMPK CC activity and suggesting the existence of a regulatory feedback CC loop between ULK1 and AMPK. {ECO:0000269|PubMed:21460634}. CC -!- SIMILARITY: Belongs to the 5'-AMP-activated protein kinase gamma CC subunit family. {ECO:0000305}. CC -!- SIMILARITY: Contains 4 CBS domains. {ECO:0000255|PROSITE- CC ProRule:PRU00703}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY348864; AAQ55224.1; -; mRNA. DR EMBL; AC116151; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC125270; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC015283; AAH15283.1; -; mRNA. DR CCDS; CCDS19130.1; -. [Q91WG5-1] DR CCDS; CCDS51437.1; -. [Q91WG5-2] DR RefSeq; NP_001164027.1; NM_001170556.1. [Q91WG5-2] DR RefSeq; NP_663376.2; NM_145401.2. [Q91WG5-1] DR UniGene; Mm.33649; -. DR ProteinModelPortal; Q91WG5; -. DR SMR; Q91WG5; 257-554. DR BioGrid; 223832; 1. DR IntAct; Q91WG5; 1. DR STRING; 10090.ENSMUSP00000030784; -. DR PhosphoSite; Q91WG5; -. DR MaxQB; Q91WG5; -. DR PaxDb; Q91WG5; -. DR PRIDE; Q91WG5; -. DR Ensembl; ENSMUST00000030784; ENSMUSP00000030784; ENSMUSG00000028944. [Q91WG5-1] DR Ensembl; ENSMUST00000114975; ENSMUSP00000110626; ENSMUSG00000028944. [Q91WG5-2] DR GeneID; 108099; -. DR UCSC; uc008wsk.2; mouse. [Q91WG5-1] DR CTD; 51422; -. DR MGI; MGI:1336153; Prkag2. DR eggNOG; KOG1764; Eukaryota. DR eggNOG; COG0517; LUCA. DR GeneTree; ENSGT00390000009849; -. DR HOGENOM; HOG000176880; -. DR HOVERGEN; HBG050431; -. DR InParanoid; Q91WG5; -. DR OMA; XVQIYEL; -. DR OrthoDB; EOG74FF0W; -. DR TreeFam; TF313247; -. DR Reactome; R-MMU-1632852; Macroautophagy. DR Reactome; R-MMU-163680; AMPK inhibits chREBP transcriptional activation activity. DR Reactome; R-MMU-200425; Import of palmitoyl-CoA into the mitochondrial matrix. DR Reactome; R-MMU-380972; Energy dependent regulation of mTOR by LKB1-AMPK. DR Reactome; R-MMU-5628897; TP53 Regulates Metabolic Genes. DR ChiTaRS; Prkag2; mouse. DR NextBio; 360062; -. DR PRO; PR:Q91WG5; -. DR Proteomes; UP000000589; Chromosome 5. DR Bgee; Q91WG5; -. DR ExpressionAtlas; Q91WG5; baseline and differential. DR Genevisible; Q91WG5; MM. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0005615; C:extracellular space; ISO:MGI. DR GO; GO:0005654; C:nucleoplasm; TAS:Reactome. DR GO; GO:0031588; C:nucleotide-activated protein kinase complex; ISO:MGI. DR GO; GO:0043531; F:ADP binding; ISO:MGI. DR GO; GO:0016208; F:AMP binding; IEA:Ensembl. DR GO; GO:0004679; F:AMP-activated protein kinase activity; TAS:MGI. DR GO; GO:0005524; F:ATP binding; ISO:MGI. DR GO; GO:0004862; F:cAMP-dependent protein kinase inhibitor activity; ISO:MGI. DR GO; GO:0008603; F:cAMP-dependent protein kinase regulator activity; ISO:MGI. DR GO; GO:0008607; F:phosphorylase kinase regulator activity; ISO:MGI. DR GO; GO:0030295; F:protein kinase activator activity; ISO:MGI. DR GO; GO:0019901; F:protein kinase binding; ISO:MGI. DR GO; GO:0032147; P:activation of protein kinase activity; ISO:MGI. DR GO; GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW. DR GO; GO:0005977; P:glycogen metabolic process; ISO:MGI. DR GO; GO:0035556; P:intracellular signal transduction; ISO:MGI. DR GO; GO:0006469; P:negative regulation of protein kinase activity; ISO:MGI. DR GO; GO:0071901; P:negative regulation of protein serine/threonine kinase activity; ISO:MGI. DR GO; GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; ISO:MGI. DR GO; GO:0045860; P:positive regulation of protein kinase activity; ISO:MGI. DR GO; GO:0019217; P:regulation of fatty acid metabolic process; ISO:MGI. DR GO; GO:0006110; P:regulation of glycolytic process; ISO:MGI. DR InterPro; IPR000644; CBS_dom. DR Pfam; PF00571; CBS; 3. DR SMART; SM00116; CBS; 4. DR PROSITE; PS51371; CBS; 4. PE 1: Evidence at protein level; KW Alternative splicing; ATP-binding; CBS domain; Complete proteome; KW Fatty acid biosynthesis; Fatty acid metabolism; Lipid biosynthesis; KW Lipid metabolism; Nucleotide-binding; Phosphoprotein; KW Reference proteome; Repeat. FT CHAIN 1 566 5'-AMP-activated protein kinase subunit FT gamma-2. FT /FTId=PRO_0000204382. FT DOMAIN 272 332 CBS 1. {ECO:0000255|PROSITE- FT ProRule:PRU00703}. FT DOMAIN 354 412 CBS 2. {ECO:0000255|PROSITE- FT ProRule:PRU00703}. FT DOMAIN 427 489 CBS 3. {ECO:0000255|PROSITE- FT ProRule:PRU00703}. FT DOMAIN 501 559 CBS 4. {ECO:0000255|PROSITE- FT ProRule:PRU00703}. FT MOTIF 367 388 AMPK pseudosubstrate. FT BINDING 299 299 AMP 1. {ECO:0000250}. FT BINDING 299 299 ATP 1. {ECO:0000250}. FT BINDING 380 380 AMP 2. {ECO:0000250}. FT BINDING 380 380 AMP 3. {ECO:0000250}. FT BINDING 380 380 ATP 2. {ECO:0000250}. FT BINDING 381 381 ATP 1. {ECO:0000250}. FT BINDING 381 381 ATP 2. {ECO:0000250}. FT BINDING 399 399 AMP 1. {ECO:0000250}. FT BINDING 399 399 ATP 1. {ECO:0000250}. FT BINDING 527 527 AMP 3. {ECO:0000250}. FT BINDING 528 528 AMP 1. {ECO:0000250}. FT BINDING 528 528 ATP 1. {ECO:0000250}. FT MOD_RES 65 65 Phosphoserine. FT {ECO:0000244|PubMed:17242355, FT ECO:0000244|PubMed:21183079}. FT MOD_RES 71 71 Phosphoserine. FT {ECO:0000244|PubMed:17242355, FT ECO:0000244|PubMed:21183079}. FT MOD_RES 73 73 Phosphoserine. FT {ECO:0000244|PubMed:17242355}. FT MOD_RES 90 90 Phosphoserine. FT {ECO:0000244|PubMed:17242355}. FT MOD_RES 138 138 Phosphoserine. FT {ECO:0000244|PubMed:17242355}. FT MOD_RES 143 143 Phosphoserine. FT {ECO:0000244|PubMed:17242355, FT ECO:0000244|PubMed:21183079}. FT MOD_RES 158 158 Phosphoserine. FT {ECO:0000244|PubMed:17242355}. FT MOD_RES 161 161 Phosphoserine. FT {ECO:0000244|PubMed:17242355, FT ECO:0000244|PubMed:21183079}. FT MOD_RES 162 162 Phosphoserine. FT {ECO:0000244|PubMed:21183079}. FT MOD_RES 165 165 Phosphothreonine. FT {ECO:0000244|PubMed:21183079}. FT MOD_RES 196 196 Phosphoserine. FT {ECO:0000244|PubMed:17242355}. FT VAR_SEQ 1 240 Missing (in isoform B). FT {ECO:0000303|Ref.1}. FT /FTId=VSP_015586. FT CONFLICT 257 257 V -> F (in Ref. 3; AAH15283). FT {ECO:0000305}. FT CONFLICT 516 516 T -> N (in Ref. 1; AAQ55224). FT {ECO:0000305}. SQ SEQUENCE 566 AA; 62949 MW; D112BFD69D1C5ACB CRC64; MGSAAMDTKK KKEVSSPGGS SGKKNPSLKR RSLRVHIPDL SSFAMPLLDG DVENSEKHSS RKVDSPFSSG SPSRGLFSRG PQPRPSSPVS APVRPKTSPG SPKTVFPFSY QESPPRSPRR MSFSGIFRSS SKESSPNSNP STSPGGIRFF SRSRKTSSVS SSPSTPTQVT KQHPFPLESY KQEPERPESR IYASSSPPDT GQRFCLAFQS PARPPLASPT YHAPLRTAVL AAAPGPAEAG MLEKLEFQEE EDSESGVYMR FMRSHKCYDI VPTSSKLVVF DTTLQVKKAF FALVANGVRA APLWESKKQS FVGMLTITDF INILHRYYKS PMVQIYELEE HKIETWRELY LQETFKPLVN ISPDASLFDA VYSLIKNKIH RLPVIDPISG NALYILTHKR ILKFLQLFMS DMPKPAFMKQ NLDELGIGTY HNIAFIHPDT PIIKALNIFV ERRISALPVV DESGKVVDIY SKFDVINLAA EKTYNNLDIT VTQALQHRSQ YFEGVVKCSK LETLETIVDR IVRAEVHRLV VVNEADSIVG IISLSDILQA LILTPAGAKQ KETETE //